LONDON (Reuters) - The World Health Organization has added new curative treatments for hepatitis C to its essential medicines list, but the U.N. agency said prices needed to fall to make them ...
Medicare spending on breakthrough medications for hepatitis C will nearly double this year, passing $9 billion, according to the Albany Daily Star. 1. The increase in spending will raise the insurance ...
Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV). Experts estimate that about 2.4 million people in the United States are living with hepatitis C—but that figure could be ...
After legal battles and lobbying efforts, thousands of people with hepatitis C are gaining earlier access to expensive drugs that can cure this condition. States that limited access to the medications ...
This story is by Alexa Ura of the Texas Tribune. A new treatment for hepatitis C is considered a breakthrough for people with the liver disease. But the high cost of the drug — about $1,000 a pill — ...
The prognosis for people with hepatitis C has improved dramatically in the last few years, thanks to the introduction of direct-acting anti-viral medications, including Harvoni (the brand name for a ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Among injection ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results